Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Aug 27, 2019
In a landmark decision, an Oklahoma judge ordered Johnson & Johnson to pay $572 million for its role in the state's opioid crisis. The ruling says the pharma giant "engaged in false and misleading marketing of both their drugs and opioids generally." Abbe Gluck, professor of medicine at Yale School of Medicine, responds.